XENE
Xenon Pharmaceuticals Inc.
NASDAQHealthcareBiotechnologyCA
Rating:C+
Company Profile
CEO
Andrea DiFabio
IPO Date
2014-11-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Xenon Pharmaceuticals Inc.
CEO
Andrea DiFabio
IPO Date
2014-11-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
| 3,500 |
| $7.38 |
| 13 Mar 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M-Exempt | Acquired | 3,750 | $0.00 |
| 13 Mar 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S-Sale | Disposed | 1,410 | $55.23 |
| 13 Mar 2026 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M-Exempt | Disposed | 3,750 | $0.00 |
| 13 Mar 2026 | DiFabio Andrea | Chief Legal Officer | M-Exempt | Acquired | 3,750 | $0.00 |
| 13 Mar 2026 | DiFabio Andrea | Chief Legal Officer | S-Sale | Disposed | 1,342 | $55.23 |
| 13 Mar 2026 | DiFabio Andrea | Chief Legal Officer | M-Exempt | Disposed | 3,750 | $0.00 |
| 13 Mar 2026 | MORTIMER IAN | director, officer: PRESIDENT & CEO | M-Exempt | Acquired | 12,500 | $0.00 |
| 13 Mar 2026 | MORTIMER IAN | director, officer: PRESIDENT & CEO | S-Sale | Disposed | 7,308 | $55.23 |